Lexington, MA, United States of America

Sethumadhavan Divakaramenon

USPTO Granted Patents = 7 

Average Co-Inventor Count = 10.4

ph-index = 4

Forward Citations = 75(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Sethumadhavan Divakaramenon

Introduction

Sethumadhavan Divakaramenon is a prominent inventor based in Lexington, MA (US). He has made significant contributions to the field of synthesis and oligonucleotide technology. With a total of 7 patents to his name, his work has advanced the understanding and application of chiral compounds and compositions.

Latest Patents

His latest patents include technologies for synthesis, which provide reagents and methods for stereoselective synthesis. These innovations are particularly useful for constructing challenging internucleotidic linkages, ensuring high yields and stereoselectivity. Another notable patent pertains to chirally controlled CpG oligonucleotide compositions, which can influence immune responses through the stereochemistry of modified internucleotidic linkages. These compositions are designed to either agonize or antagonize immune responses, showcasing the versatility of his research.

Career Highlights

Sethumadhavan Divakaramenon is currently associated with Wave Life Sciences Ltd., where he continues to push the boundaries of scientific research. His work has not only contributed to the academic community but has also had practical implications in biotechnology and medicine.

Collaborations

He has collaborated with notable colleagues such as Naoki Iwamoto and Genliang Lu, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Sethumadhavan Divakaramenon exemplifies the spirit of innovation in the field of synthesis and oligonucleotide technology. His contributions are paving the way for future advancements in these critical areas of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…